FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to novel compounds represented by he general formula (I) 
and their salts possessing properties of VLA-4 inhibitors, to a medicinal agent based on thereof and their using for preparing a medicinal agent used in treatment of diseases caused by the cellular adhesion. In compound of the formula (I) W represents the group of the following formula: W1-A1-W2- (i) or W3-A1-W4 (ii); R represents -CH2-; M represents the group of the following formula (iii): 
or the formula (iv): 
. Values of substitutes W1, W2, W3, W4, A1, A, A3, Q, Q, R10, R11, R12, R13, R14, R15, R16, R16a, R17, Y, Y3, Z and Z Z1 are given in the invention claim.
EFFECT: valuable medicinal properties of inhibitors.
21 cl, 3 tbl, 173 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIPEPTIDYL PEPTIDASE-IV INHIBITORS | 2010 |
|
RU2574410C2 |
| FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS | 2014 |
|
RU2704112C2 |
| CYCLOALKENYLARYLIC DERIVATIVES FOR INHIBITING TRANSPORT PROTEIN CHOLESTERIN ESTERS | 2012 |
|
RU2597266C2 |
| PHENICOL ANTIBACTERIAL AGENTS | 2013 |
|
RU2593204C2 |
| BIARYL- OR HETEROCYCLIC BIARYL-SUBSTITUTED DERIVATIVES OF CYCLOHEXENE AS CETP INHIBITORS | 2014 |
|
RU2627361C2 |
| SUBSTITUTED TRICYCLIC COMPOUNDS AND METHOD OF APPLICATION | 2016 |
|
RU2744766C2 |
| CONDENSED SUBSTITUTED AMINOPYRROLIDINE DERIVATIVE | 2007 |
|
RU2443698C2 |
| RMT5 INHIBITORS | 2019 |
|
RU2814198C2 |
| SUBSTITUTED CARBONUCLEOSIDES DERIVATIVES USED AS ANTICANCER AGENTS | 2017 |
|
RU2712944C1 |
| NOVEL PHENYL PYRROLE DERIVATIVE | 2009 |
|
RU2470917C2 |
